Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,086

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline

Open access
Crouser, Elliott D., Maier, Lisa A., Wilson, Kevin C., Bonham, Catherine A., Morgenthau, Adam S., Patterson, Karen C., Abston, Eric, Bernstein, Richard C., Blankstein, Ron, Chen, Edward S., Culver, Daniel A., Drake, Wonder, Drent, Marjolein, Gerke, Alicia K., Ghobrial, Michael, Govender, Praveen, Hamzeh, Nabeel, James, W. Ennis, Judson, Marc A., Kellermeyer, Liz, Knight, Shandra, Koth, Laura L., Poletti, Venerino, Raman, Subha V., Tukey, Melissa H., Westney, Gloria E., Baughman, Robert P.·2020·American Journal of Respiratory and Critical Care Medicine
DOI 10.1164/rccm.202002-0251st
Open this paper in CoChat — free account

Abstract

Abstract Background The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternative causes of granulomatous disease. There are no universally accepted measures to determine if each diagnostic criterion has been satisfied; therefore, the diagnosis of sarcoidosis is never fully secure. Methods Systematic reviews and, when appropriate, meta-analyses were performed to summarize the best available evidence. The evidence was appraised using the Grading of Recommendations, Assessment, Development, and Evaluation approach and then discussed by a multidisciplinary panel. Recommendations for or against various diagnostic tests were formulated and graded after the expert panel weighed desirable and undesirable consequences, certainty of estimates, feasibility, and acceptability. Results The clinical presentation, histopathology, and exclusion of alternative diagnoses were summarized. On the basis of the available evidence, the expert committee made 1 strong recommendation for baseline serum calcium testing, 13 conditional recommendations, and 1 best practice statement. All evidence was very low quality. Conclusions The panel used systematic reviews of the evidence to inform clinical recommendations in favor of or against various diagnostic tests in patients with suspected or known sarcoidosis. The evidence and recommendations should be revisited as new evidence becomes available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.202002-0251st

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 201

  1. Cozier, 2011, Sarcoidosis in black women in the United States: data from the Black Women’s Health Study, Chest, 139, 144, 10.1378/chest.10-0413 · DOI · Paper page
  2. Tukey, 2013, Mortality among African American women with sarcoidosis: data from the Black Women’s Health Study, Sarcoidosis Vasc Diffuse Lung Dis, 30, 128
  3. Hunninghake, 1999, ATS/ERS/WASOG statement on sarcoidosis: American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders, Sarcoidosis Vasc Diffuse Lung Dis, 16, 149
  4. Grunewald, 2007, Sex-specific manifestations of Löfgren’s syndrome, Am J Respir Crit Care Med, 175, 40, 10.1164/rccm.200608-1197OC · doi:10.1164/rccm.200608-1197oc
  5. Spiteri, 1985, Lupus pernio: a clinico-radiological study of thirty-five cases, Br J Dermatol, 112, 315, 10.1111/j.1365-2133.1985.tb04859.x · DOI
  6. Poate, 2008, Orofacial presentations of sarcoidosis: a case series and review of the literature, Br Dent J, 205, 437, 10.1038/sj.bdj.2008.892 · DOI
  7. Winterbauer, 1973, Clinical interpretation of bilateral hilar adenopathy, Ann Intern Med, 78, 65, 10.7326/0003-4819-78-1-65 · doi:10.7326/0003-4819-78-1-65
  8. Judson, 1999, Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group: a case control etiologic study of sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 16, 75
  9. Judson, 2014, The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool, Sarcoidosis Vasc Diffuse Lung Dis, 31, 19
  10. Birnie, 2014, HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis, Heart Rhythm, 11, 1305, 10.1016/j.hrthm.2014.03.043 · DOI · Paper page
  11. Stern, 2018, Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group, JAMA Neurol, 75, 1546, 10.1001/jamaneurol.2018.2295 · DOI · Paper page
  12. Keijsers, 2015, Chest imaging, Clin Chest Med, 36, 603, 10.1016/j.ccm.2015.08.004 · DOI
  13. Rosen, 2015, Four decades of necrotizing sarcoid granulomatosis: what do we know now?, Arch Pathol Lab Med, 139, 252, 10.5858/arpa.2014-0051-RA · DOI
  14. Costabel, 1999, ATS/ERS/WASOG statement on sarcoidosis, Eur Respir J, 14, 735, 10.1034/j.1399-3003.1999.14d02.x · DOI · Paper page
  15. Amicosante, 2011, IGRAs for tuberculosis in sarcoidosis patients: is the immune response to mycobacteria helpful in the differential diagnosis or still a confounding factor?, Sarcoidosis Vasc Diffuse Lung Dis, 28, 85
  16. Pai, 2016, Tuberculosis diagnostics: state of the art and future directions, Microbiol Spectr, 4, TBTB2-0019-2016, 10.1128/microbiolspec.TBTB2-0019-2016 · DOI
  17. Shinnick, 1995, Diagnostic mycobacteriology laboratory practices, Clin Infect Dis, 21, 291, 10.1093/clinids/21.2.291 · DOI
  18. Nin, 2016, Thoracic lymphadenopathy in benign diseases: a state of the art review, Respir Med, 112, 10, 10.1016/j.rmed.2016.01.021 · doi:10.1016/j.rmed.2016.01.021
  19. Balmes, 2014, An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease, Am J Respir Crit Care Med, 190, e34, 10.1164/rccm.201409-1722ST · doi:10.1164/rccm.201409-1722st
  20. Meyer, 2012, An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease, Am J Respir Crit Care Med, 185, 1004, 10.1164/rccm.201202-0320ST · DOI · Paper page
  21. Chopra, 2018, Drug-induced sarcoidosis-like reactions, Chest, 154, 664, 10.1016/j.chest.2018.03.056 · DOI · Paper page
  22. Payá-Llorente, 2018, Mediastinal sarcoid-like reaction in cancer patients, Pulmonology, 24, 61, 10.1016/j.pulmoe.2017.12.003 · doi:10.1016/j.pulmoe.2017.12.003
  23. Gong, 2009, Clonal status and clinicopathological feature of Erdheim-Chester disease, Pathol Res Pract, 205, 601, 10.1016/j.prp.2009.02.004 · DOI
  24. Okazaki, 2011, Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease, J Gastroenterol, 46, 277, 10.1007/s00535-011-0386-x · DOI · Paper page
  25. Carmona, 2016, Pulmonary sarcoidosis: diagnosis and treatment, Mayo Clin Proc, 91, 946, 10.1016/j.mayocp.2016.03.004 · doi:10.1016/j.mayocp.2016.03.004
  26. Stone, 2012, IgG4-related disease, N Engl J Med, 366, 539, 10.1056/NEJMra1104650 · DOI · Paper page
  27. Reich, 1998, Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis, Chest, 113, 147, 10.1378/chest.113.1.147 · DOI
  28. Boujaoude, 2012, Endobronchial ultrasound with transbronchial needle aspiration in the diagnosis of bilateral hilar and mediastinal lymphadenopathy, J Bronchology Interv Pulmonol, 19, 19, 10.1097/LBR.0b013e3182442b89 · doi:10.1097/lbr.0b013e3182442b89
  29. Fritscher-Ravens, 2000, Diagnosing sarcoidosis using endosonography-guided fine-needle aspiration, Chest, 118, 928, 10.1378/chest.118.4.928 · DOI
  30. Garwood, 2007, Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis, Chest, 132, 1298, 10.1378/chest.07-0998 · doi:10.1378/chest.07-0998
  31. Hong, 2013, Usefulness of endobronchial ultrasound guided transbronchial needle aspiration for diagnosis of sarcoidosis, Yonsei Med J, 5, 1416, 10.3349/ymj.2013.54.6.1416 · doi:10.3349/ymj.2013.54.6.1416
  32. Iwashita, 2008, The yield of endoscopic ultrasound-guided fine needle aspiration for histological diagnosis in patients suspected of stage I sarcoidosis, Endoscopy, 40, 400, 10.1055/s-2007-995593 · doi:10.1055/s-2007-995593
  33. Koerner, 1975, Transbronchinal lung biopsy for the diagnosis of sarcoidosis, N Engl J Med, 293, 268, 10.1056/NEJM197508072930603 · doi:10.1056/nejm197508072930603
  34. Koonitz, 1976, Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis, Ann Intern Med, 85, 64, 10.7326/0003-4819-85-1-64 · doi:10.7326/0003-4819-85-1-64
  35. Leonard, 1997, Bronchoscopic diagnosis of sarcoidosis, Eur Respir J, 10, 2722, 10.1183/09031936.97.10122722 · doi:10.1183/09031936.97.10122722
  36. Oki, 2007, Real-time endobronchial ultrasound-guided transbronchial needle aspiration is useful for diagnosing sarcoidosis, Respirology, 12, 863, 10.1111/j.1440-1843.2007.01145.x · doi:10.1111/j.1440-1843.2007.01145.x
  37. Pakhale, 2006, Has mediastinoscopy still a role in suspected stage I sarcoidosis?, Sarcoidosis Vasc Diffuse Lung Dis, 23, 66
  38. Pauli, 1984, Transbronchial needle aspiration in the diagnosis of sarcoidosis, Chest, 85, 482, 10.1378/chest.85.4.482 · doi:10.1378/chest.85.4.482
  39. Ribeiro, 2014, Diagnosis of sarcoidosis in the endobronchial ultrasound-guided transbronchial needle aspiration era, Rev Port Pneumol, 20, 237, 10.1016/j.rppneu.2014.02.005 · doi:10.1016/j.rppneu.2014.02.005
  40. Trisolini, 2004, Transbronchial needle aspiration improves the diagnostic yield of bronchoscopy in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 21, 147
  41. Oki, 2012, Prospective study of endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of sarcoidosis, J Thorac Cardiovasc Surg, 143, 1324, 10.1016/j.jtcvs.2012.01.040 · doi:10.1016/j.jtcvs.2012.01.040
  42. Oki, 2013, Transesophageal bronchoscopic ultrasound-guided fine needle aspiration for diagnosis of sarcoidosis, Respiration, 85, 137, 10.1159/000345207 · doi:10.1159/000345207
  43. Oki, 2018, How many passes are needed for endobronchial ultrasound-guided transbronchial needle aspiration for sarcoidosis? A prospective multicenter study, Respiration, 95, 251, 10.1159/000485661 · doi:10.1159/000485661
  44. Yanardağ, 2006, Clinical value of mediastinoscopy in the diagnosis of sarcoidosis: an analysis of 68 cases, Thorac Cardiovasc Surg, 54, 198, 10.1055/s-2005-872996 · doi:10.1055/s-2005-872996
  45. Drent, 2003, Sarcoidosis: assessment of disease severity using HRCT, Eur Radiol, 13, 2462, 10.1007/s00330-003-1965-x · DOI
  46. Nakajima, 2009, The role of EBUS-TBNA for the diagnosis of sarcoidosis: comparisons with other bronchoscopic diagnostic modalities, Respir Med, 103, 1796, 10.1016/j.rmed.2009.07.013 · DOI · Paper page
  47. Gupta, 2014, Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis, Chest, 146, 547, 10.1378/chest.13-2339 · DOI · Paper page
  48. Madan, 2017, Conventional transbronchial needle aspiration versus endobronchial ultrasound-guided transbronchial needle aspiration, with or without rapid on-site evaluation, for the diagnosis of sarcoidosis: a randomized controlled trial, J Bronchology Interv Pulmonol, 24, 48, 10.1097/LBR.0000000000000339 · DOI
  49. von Bartheld, 2013, Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial, JAMA, 309, 2457, 10.1001/jama.2013.5823 · DOI · Paper page
  50. Friedel, 1964, The significance of bronchoscopy and mediastinoscopy for the diagnosis of sarcoidosis [in German], Z Tuberk Erkrank Thoraxorg, 121, 152
  51. Aragaki-Nakahodo, 2017, The complimentary role of transbronchial lung cryobiopsy and endobronchial ultrasound fine needle aspiration in the diagnosis of sarcoidosis, Respir Med, 131, 65, 10.1016/j.rmed.2017.08.003 · DOI
  52. Balwan, 2018, Endobronchial ultrasound-guided transbronchial needle aspiration using 19-G needle for sarcoidosis, J Bronchology Interv Pulmonol, 25, 260, 10.1097/LBR.0000000000000502 · doi:10.1097/lbr.0000000000000502
  53. Szlubowski, 2008, Ultrasound guided transbronchial needle aspiration as a diagnostic tool for lung cancer and sarcoidosis [in Polish], Pneumonol Alergol Pol, 76, 229
  54. Li, 2014, A randomized controlled study of conventional TBNA versus EBUS-TBNA for diagnosis of suspected stage I and II sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 31, 211
  55. Low, 2014, Use of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of granulomatous mediastinal lymphadenopathy, Ann Acad Med Singapore, 43, 250, 10.47102/annals-acadmedsg.V43N5p250 · doi:10.47102/annals-acadmedsg.v43n5p250
  56. Navasakulpong, 2016, Yield of EBUS-TBNA for the diagnosis of sarcoidosis: impact of operator and cytopathologist experience, BMJ Open Respir Res, 3, e000144, 10.1136/bmjresp-2016-000144 · doi:10.1136/bmjresp-2016-000144
  57. Raddaoui, 2014, Utility of endoscopic ultrasound-guided transbronchial fine-needle cytology in the diagnosis of sarcoidosis: a Saudi experience, Cytojournal, 11, 31, 10.4103/1742-6413.146118 · doi:10.4103/1742-6413.146118
  58. Tremblay, 2009, A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis, Chest, 136, 340, 10.1378/chest.08-2768 · DOI · Paper page
  59. Wong, 2007, Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis, Eur Respir J, 29, 1182, 10.1183/09031936.00028706 · doi:10.1183/09031936.00028706
  60. Dziedzic, 2017, The role of EBUS-TBNA and standard bronchoscopic modalities in the diagnosis of sarcoidosis, Clin Respir J, 11, 58, 10.1111/crj.12304 · DOI
  61. Tucker, 1970, Mediastinoscopy with special reference to the diagnosis of sarcoid, Ann Otol Rhinol Laryngol, 79, 937, 10.1177/000348947007900510 · doi:10.1177/000348947007900510
  62. Carlens, 1959, Mediastinoscopy: a method for inspection and tissue biopsy in the superior mediastinum, Dis Chest, 36, 343, 10.1378/chest.36.4.343 · doi:10.1378/chest.36.4.343
  63. Nielsen, 1966, Mediastinoscopy: an analysis of 223 cases, Dan Med Bull, 13, 193
  64. Maassen, 1967, Results and significance of mediastinoscopy and other procedures of thoracic biopsy [in German], Tuberk Grenzgeb Einzeldarst, 19, 1
  65. Jepsen, 1966, Mediastinoscopy
  66. Löfgren, 1964, Principles and procedures for obtaining biopsies in sarcoidosis, Acta Med Scand Suppl, 425, 225, 10.1111/j.0954-6820.1964.tb05756.x · doi:10.1111/j.0954-6820.1964.tb05756.x
  67. Palva, 1964, Mediastinal sarcoidosis, Acta Otolaryngol Suppl, 188
  68. Pätiälä, 1964, Observations on the significance of mediastinoscopy in the diagnosis of sarcoidosis, Acta Med Scand Suppl, 425, 239, 10.1111/j.0954-6820.1964.tb05761.x · doi:10.1111/j.0954-6820.1964.tb05761.x
  69. Mikhail, 1971, Mediastinoscopy: a diagnostic procedure in hilar and paratracheal lymphadenopathy, Postgrad Med J, 47, 698, 10.1136/pgmj.47.553.698 · doi:10.1136/pgmj.47.553.698
  70. Bergh, 1964, Mediastinal exploration by the technique of Carlens, Dis Chest, 46, 399, 10.1378/chest.46.4.399 · doi:10.1378/chest.46.4.399
  71. Lemaire, 2006, Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate, Ann Thorac Surg, 82, 1185, 10.1016/j.athoracsur.2006.05.023 · doi:10.1016/j.athoracsur.2006.05.023
  72. Cybulsky, 1994, Mediastinoscopy as a routine outpatient procedure, Ann Thorac Surg, 58, 176, 10.1016/0003-4975(94)91095-2 · doi:10.1016/0003-4975(94)91095-2
  73. Sehgal, 2016, Endosonography versus mediastinoscopy in mediastinal staging of lung cancer: systematic review and meta-analysis, Ann Thorac Surg, 102, 1747, 10.1016/j.athoracsur.2016.05.110 · DOI
  74. Navani, 2012, Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial, Am J Respir Crit Care Med, 186, 255, 10.1164/rccm.201203-0393OC · DOI
  75. Steinfort, 2010, Cost-benefit of minimally invasive staging of non–small cell lung cancer: a decision tree sensitivity analysis, J Thorac Oncol, 5, 1564, 10.1097/JTO.0b013e3181e8b2e6 · doi:10.1097/jto.0b013e3181e8b2e6
  76. Li, 2015, Mediastinoscopy after negative endoscopic mediastinal nodal staging: can it be omitted?, Eur Respir J, 46, 1846, 10.1183/13993003.01166-2015 · doi:10.1183/13993003.01166-2015
  77. Shrager, 2010, Mediastinoscopy: still the gold standard, Ann Thorac Surg, 89, S2084, 10.1016/j.athoracsur.2010.02.098 · doi:10.1016/j.athoracsur.2010.02.098
  78. Hu, 2016, Endobronchial ultrasound-guided transbronchial needle aspiration versus standard bronchoscopic modalities for diagnosis of sarcoidosis: a meta-analysis, Chin Med J (Engl), 129, 1607, 10.4103/0366-6999.184458 · doi:10.4103/0366-6999.184458
  79. Gnass, 2015, Comparison of conventional and ultrasound-guided needle biopsy techniques in the diagnosis of sarcoidosis: a randomized trial, Pol Arch Med Wewn, 125, 321, 10.20452/pamw.2828 · doi:10.20452/pamw.2828
  80. Liran, 2019, A novel, stepwise approach combining conventional and endobronchial ultrasound needle aspiration for mediastinal lymph node sampling, Endosc Ultrasound, 8, 31, 10.4103/eus.eus_29_17 · doi:10.4103/eus.eus_29_17
  81. Acharya, 2018, Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients, Ophthalmology, 125, 119, 10.1016/j.ophtha.2017.07.006 · doi:10.1016/j.ophtha.2017.07.006
  82. Birnbaum, 2015, Sarcoidosis in the national veteran population: association of ocular inflammation and mortality, Ophthalmology, 122, 934, 10.1016/j.ophtha.2015.01.003 · doi:10.1016/j.ophtha.2015.01.003
  83. Ungprasert, 2019, Clinical characteristics of ocular sarcoidosis: a population-based study 1976–2013, Ocul Immunol Inflamm, 27, 389, 10.1080/09273948.2017.1386791 · DOI
  84. Lee, 2009, Ocular sarcoidosis in a Korean population, J Korean Med Sci, 24, 413, 10.3346/jkms.2009.24.3.413 · DOI
  85. Evans, 2007, Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis, Ophthalmology, 114, 325, 10.1016/j.ophtha.2006.05.074 · DOI
  86. Dróbecka, 1999, Ocular manifestations in sarcoidosis [in Polish], Klin Oczna, 101, 201
  87. Atmaca, 2009, Ocular involvement in sarcoidosis, Ocul Immunol Inflamm, 17, 91, 10.1080/09273940802596526 · doi:10.1080/09273940802596526
  88. Baughman, 2001, Clinical characteristics of patients in a case control study of sarcoidosis, Am J Respir Crit Care Med, 164, 1885, 10.1164/ajrccm.164.10.2104046 · DOI · Paper page
  89. Judson, 2012, The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States, Sarcoidosis Vasc Diffuse Lung Dis, 29, 119
  90. Jabs, 1986, Ocular involvement in chronic sarcoidosis, Am J Ophthalmol, 102, 297, 10.1016/0002-9394(86)90001-2 · DOI · Paper page
  91. James, 1964, Ocular sarcoidosis, Br J Ophthalmol, 48, 461, 10.1136/bjo.48.9.461 · doi:10.1136/bjo.48.9.461
  92. Siltzbach, 1974, Course and prognosis of sarcoidosis around the world, Am J Med, 57, 847, 10.1016/0002-9343(74)90160-0 · DOI
  93. Jackson, 1970, Ocular sarcoidosis, Postgrad Med J, 46, 501, 10.1136/pgmj.46.538.501 · doi:10.1136/pgmj.46.538.501
  94. Obenauf, 1978, Sarcoidosis and its ophthalmic manifestations, Am J Ophthalmol, 86, 648, 10.1016/0002-9394(78)90184-8 · doi:10.1016/0002-9394(78)90184-8
  95. Khanna, 2007, Pattern of ocular manifestations in patients with sarcoidosis in developing countries, Acta Ophthalmol Scand, 85, 609, 10.1111/j.1600-0420.2006.00791.x · doi:10.1111/j.1600-0420.2006.00791.x
  96. Sungur, 2013, Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey, Ocul Immunol Inflamm, 21, 455, 10.3109/09273948.2013.775311 · doi:10.3109/09273948.2013.775311
  97. Sheu, 2010, Ocular sarcoidosis in southern taiwan, Ocul Immunol Inflamm, 18, 152, 10.3109/09273941003637502 · doi:10.3109/09273941003637502
  98. Baughman, 2012, Management of ocular sarcoidosis, Sarc Vasc Diff Lung Dis, 29, 26
  99. Morimoto, 2008, Epidemiology of sarcoidosis in Japan, Eur Respir J, 31, 372, 10.1183/09031936.00075307 · DOI · Paper page
  100. Jamilloux, 2014, Sarcoidosis and uveitis, Autoimmun Rev, 13, 840, 10.1016/j.autrev.2014.04.001 · DOI · Paper page
  101. Pefkianaki, 2011, Ocular disease awareness and pattern of ocular manifestation in patients with biopsy-proven lung sarcoidosis, J Ophthalmic Inflamm Infect, 1, 141, 10.1007/s12348-011-0029-7 · doi:10.1007/s12348-011-0029-7
  102. Mochizuki, 2019, Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis, Br J Ophthalmol, 103, 1418, 10.1136/bjophthalmol-2018-313356 · doi:10.1136/bjophthalmol-2018-313356
  103. Ohara, 1992, Intraocular manifestations of systemic sarcoidosis, Jpn J Ophthalmol, 36, 452
  104. Yang, 2017, Ocular sarcoidosis: new diagnostic modalities and treatment, Curr Opin Pulm Med, 23, 458, 10.1097/MCP.0000000000000409 · doi:10.1097/mcp.0000000000000409
  105. Bergner, 2003, Frequency of kidney disease in chronic sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 20, 126
  106. Richmond, 1981, Renal disease and sarcoidosis, Med J Aust, 2, 36, 10.5694/j.1326-5377.1981.tb132055.x · doi:10.5694/j.1326-5377.1981.tb132055.x
  107. Ricker, 1949, Sarcoidosis; a clinicopathologic review of 300 cases, including 22 autopsies, Am J Clin Pathol, 19, 725, 10.1093/ajcp/19.8.725 · DOI · Paper page
  108. MacSearraigh, 1978, Sarcoidosis with renal involvement, Postgrad Med J, 54, 528, 10.1136/pgmj.54.634.528 · doi:10.1136/pgmj.54.634.528
  109. Lebacq, 1970, Renal involvement in sarcoidosis, Postgrad Med J, 46, 526, 10.1136/pgmj.46.538.526 · doi:10.1136/pgmj.46.538.526
  110. Löfgren, 1957, Renal complications in sarcoidosis; functional and biopsy studies, Acta Med Scand, 159, 295, 10.1111/j.0954-6820.1957.tb00137.x · doi:10.1111/j.0954-6820.1957.tb00137.x
  111. Löffler, 2015, Renal sarcoidosis: epidemiological and follow-up data in a cohort of 27 patients, Sarcoidosis Vasc Diffuse Lung Dis, 31, 306
  112. Stehlé, 2013, Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study, Orphanet J Rare Dis, 8, 65, 10.1186/1750-1172-8-65 · DOI
  113. Hilderson, 2014, Treatment of renal sarcoidosis: is there a guideline? Overview of the different treatment options, Nephrol Dial Transplant, 29, 1841, 10.1093/ndt/gft442 · DOI
  114. Mahévas, 2009, Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients, Medicine (Baltimore), 88, 98, 10.1097/MD.0b013e31819de50f · DOI · Paper page
  115. Cremers, 2012, Liver-test abnormalities in sarcoidosis, Eur J Gastroenterol Hepatol, 24, 17, 10.1097/MEG.0b013e32834c7b71 · DOI
  116. Kahi, 2006, Hepatobiliary disease in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 23, 117
  117. Vatti, 1997, Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases, Sarcoidosis Vasc Diffuse Lung Dis, 14, 73
  118. Kennedy, 2006, Natural history of hepatic sarcoidosis and its response to treatment, Eur J Gastroenterol Hepatol, 18, 721, 10.1097/01.meg.0000223911.85739.38 · doi:10.1097/01.meg.0000223911.85739.38
  119. Cowdell, 1954, Sarcoidosis: with special reference to diagnosis and prognosis, Q J Med, 23, 29
  120. Baughman, 2003, Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis, Arch Intern Med, 163, 615, 10.1001/archinte.163.5.615 · doi:10.1001/archinte.163.5.615
  121. Bakker, 2012, Sarcoidosis of the liver: to treat or not to treat?, Neth J Med, 70, 349
  122. Swigris, 2011, Sarcoidosis-related mortality in the United States from 1988 to 2007, Am J Respir Crit Care Med, 183, 1524, 10.1164/rccm.201010-1679OC · DOI · Paper page
  123. Van Brusselen, 2012, Budd-Chiari syndrome as presenting symptom of hepatic sarcoidosis in a child, with recurrence after liver transplantation, Pediatr Transplant, 16, E58, 10.1111/j.1399-3046.2011.01535.x · doi:10.1111/j.1399-3046.2011.01535.x
  124. Zeimer, 1998, Parathyroid-hormone-related protein in sarcoidosis, Am J Pathol, 152, 17
  125. Koeffler, 1985, gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages, Biochem Biophys Res Commun, 127, 596, 10.1016/S0006-291X(85)80202-3 · DOI · Paper page
  126. Sexton, 2016, Serum fibroblastic growth factor 23 in acute sarcoidosis and normal kidney function, Sarcoidosis Vasc Diffuse Lung Dis, 33, 139
  127. Baughman, 2013, Calcium and vitamin D metabolism in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 30, 113
  128. Longcope, 1952, A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital, Medicine (Baltimore), 31, 1, 10.1097/00005792-195202000-00001 · DOI · Paper page
  129. James, 1956, Diagnosis and treatment of sarcoidosis, BMJ, 2, 900, 10.1136/bmj.2.4998.900 · doi:10.1136/bmj.2.4998.900
  130. Mayock, 1963, Manifestations of sarcoidosis: analysis of 145 patients with a review of nine series selected from the literature, Am J Med, 35, 67, 10.1016/0002-9343(63)90165-7 · DOI
  131. McCort, 1947, Sarcoidosis a clinical and roentgenologic study of twenty-eight proved cases, Arch Intern Med (Chic), 80, 293, 10.1001/archinte.1947.00220150003001 · doi:10.1001/archinte.1947.00220150003001
  132. Ferguson, 1958, Sarcoidosis; study of twenty-nine cases, with a review of splenic, hepatic, mucous-membrane; retinal, and joint manifestations, AMA Arch Intern Med, 101, 1065, 10.1001/archinte.1958.00260180055007 · doi:10.1001/archinte.1958.00260180055007
  133. Cummings, 1959, Epidemiologic and clinical observations in sarcoidosis, Ann Intern Med, 50, 879, 10.7326/0003-4819-50-4-879 · doi:10.7326/0003-4819-50-4-879
  134. Kavathia, 2010, Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis, Respir Med, 104, 564, 10.1016/j.rmed.2009.12.004 · doi:10.1016/j.rmed.2009.12.004
  135. Tebben, 2016, Vitamin D–mediated hypercalcemia: mechanisms, diagnosis, and treatment, Endocr Rev, 37, 521, 10.1210/er.2016-1070 · DOI · Paper page
  136. Kamphuis, 2014, Calcium and vitamin D in sarcoidosis: is supplementation safe?, J Bone Miner Res, 29, 2498, 10.1002/jbmr.2262 · doi:10.1002/jbmr.2262
  137. Bolland, 2013, Randomised controlled trial of vitamin D supplementation in sarcoidosis, BMJ Open, 3, e003562, 10.1136/bmjopen-2013-003562 · DOI
  138. Capolongo, 2016, Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis, J Investig Med, 64, 1025, 10.1136/jim-2016-000101 · DOI
  139. Thomas, 1987, Current concepts of the pathogenesis of sarcoidosis, Am Rev Respir Dis, 135, 747
  140. Browne, 1978, Bone marrow sarcoidosis, JAMA, 240, 2654, 10.1001/jama.1978.03290240054026 · doi:10.1001/jama.1978.03290240054026
  141. Lower, 1988, The anemia of sarcoidosis, Sarcoidosis, 5, 51
  142. Yanardağ, 2002, Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples, Haematologia (Budap), 32, 419
  143. Gupta, 2002, Haematological abnormalities in patients of sarcoidosis, Indian J Chest Dis Allied Sci, 44, 233
  144. Sharma, 2001, Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis, J Assoc Physicians India, 49, 697
  145. Israel, 1958, Sarcoidosis; clinical observation on one hundred sixty cases, AMA Arch Intern Med, 102, 766, 10.1001/archinte.1958.00260220082008 · doi:10.1001/archinte.1958.00260220082008
  146. Crouser, 2010, The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti–tumor necrosis factor-alpha therapy, Chest, 137, 1432, 10.1378/chest.09-2576 · DOI
  147. Sweiss, 2010, Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations, PLoS One, 5, e9088, 10.1371/journal.pone.0009088 · DOI
  148. Mehta, 2008, Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing, Chest, 133, 1426, 10.1378/chest.07-2784 · DOI · Paper page
  149. Burstow, 1989, Two-dimensional echocardiographic findings in systemic sarcoidosis, Am J Cardiol, 63, 478, 10.1016/0002-9149(89)90323-8 · DOI · Paper page
  150. Nagao, 2015, Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis, Int J Cardiol, 189, 1, 10.1016/j.ijcard.2015.03.175 · DOI
  151. Langer, 1995, Electrocardiographic changes in patients with intrathoracic sarcoidosis: influence on prognosis, Sarcoidosis, 12, 42
  152. Suzuki, 1994, Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis, Chest, 106, 1021, 10.1378/chest.106.4.1021 · DOI
  153. Hena, 2018, Clinical course of sarcoidosis in world trade center-exposed firefighters, Chest, 153, 114, 10.1016/j.chest.2017.10.014 · DOI
  154. Vaidya, 2018, The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: a systematic review, J Interv Card Electrophysiol, 53, 63, 10.1007/s10840-018-0410-7 · DOI
  155. Ohira, 2016, Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis, Eur J Nucl Med Mol Imaging, 43, 259, 10.1007/s00259-015-3181-8 · DOI
  156. Smedema, 2005, Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands, Chest, 128, 30, 10.1378/chest.128.1.30 · DOI
  157. Patel, 2009, Detection of myocardial damage in patients with sarcoidosis, Circulation, 120, 1969, 10.1161/CIRCULATIONAHA.109.851352 · DOI · Paper page
  158. Patel, 2011, Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study, Eur J Heart Fail, 13, 1231, 10.1093/eurjhf/hfr099 · DOI
  159. Greulich, 2013, CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis, JACC Cardiovasc Imaging, 6, 501, 10.1016/j.jcmg.2012.10.021 · DOI · Paper page
  160. Cain, 2014, Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias, Am J Cardiol, 113, 1556, 10.1016/j.amjcard.2014.01.434 · DOI
  161. Kouranos, 2017, Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis, JACC Cardiovasc Imaging, 10, 1437, 10.1016/j.jcmg.2016.11.019 · DOI · Paper page
  162. Stanton, 2017, The utility of cardiac magnetic resonance imaging in the diagnosis of cardiac sarcoidosis, Heart Lung Circ, 26, 1191, 10.1016/j.hlc.2017.02.021 · doi:10.1016/j.hlc.2017.02.021
  163. Nadel, 2015, Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death, Eur Heart J Cardiovasc Imaging, 16, 634
  164. Bravo, 2017, Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging, Int J Cardiol, 241, 457, 10.1016/j.ijcard.2017.03.033 · doi:10.1016/j.ijcard.2017.03.033
  165. Ohira, 2008, Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis, Eur J Nucl Med Mol Imaging, 35, 933, 10.1007/s00259-007-0650-8 · DOI · Paper page
  166. Wicks, 2018, Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis, Eur Heart J Cardiovasc Imaging, 19, 757, 10.1093/ehjci/jex340 · DOI · Paper page
  167. Yokoyama, 2015, Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis, Int J Cardiol, 195, 180, 10.1016/j.ijcard.2015.05.075 · DOI
  168. Sperry, 2018, Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis, JACC Cardiovasc Imaging, 11, 336, 10.1016/j.jcmg.2017.04.020 · doi:10.1016/j.jcmg.2017.04.020
  169. Sgard, 2018, Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis, Clin Radiol, 74, 81, e9, 10.1016/j.crad.2018.09.015 · DOI
  170. Hiraga, 2007, Diagnostic standard and guidelines for sarcoidosis, Jpn J Sarcoidosis Granulomatous Disord, 27, 89
  171. Hulten, 2016, Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis, Circ Cardiovasc Imaging, 9, e005001, 10.1161/CIRCIMAGING.116.005001 · DOI · Paper page
  172. Shafee, 2012, Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis, J Cardiol, 60, 448, 10.1016/j.jjcc.2012.08.002 · DOI
  173. Agoston-Coldea, 2016, High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis, Int J Cardiol, 222, 950, 10.1016/j.ijcard.2016.07.233 · doi:10.1016/j.ijcard.2016.07.233
  174. Flores, The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis, J Nucl Cardiol
  175. Alvi, 2019, Repeatability and optimization of FDG positron emission tomography for evaluation of cardiac sarcoidosis, JACC Cardiovasc Imaging, 12, 1284, 10.1016/j.jcmg.2019.01.011 · doi:10.1016/j.jcmg.2019.01.011
  176. Vita, 2018, Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis, Circ Cardiovasc Imaging, 11, e007030, 10.1161/CIRCIMAGING.117.007030 · DOI · Paper page
  177. Martineau, 2019, Imaging cardiac sarcoidosis with FLT-PET compared with FDG/perfusion-PET: a prospective pilot study, JACC Cardiovasc Imaging, 12, 2280, 10.1016/j.jcmg.2019.06.020 · doi:10.1016/j.jcmg.2019.06.020
  178. Hotta, 2018, 11C-4DST PET/CT imaging of cardiac sarcoidosis: comparison with 18-F-FDG and cardiac MRI, Clin Nucl Med, 43, 458, 10.1097/RLU.0000000000002059 · doi:10.1097/rlu.0000000000002059
  179. Alhamad, 2010, Sarcoidosis-associated pulmonary hypertension: clinical features and outcomes in Arab patients, Ann Thorac Med, 5, 86, 10.4103/1817-1737.62471 · doi:10.4103/1817-1737.62471
  180. Parikh, 2019, Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension, Sci Rep, 9, 4061, 10.1038/s41598-019-40030-w · DOI
  181. Bourbonnais, 2008, Clinical predictors of pulmonary hypertension in sarcoidosis, Eur Respir J, 32, 296, 10.1183/09031936.00175907 · DOI · Paper page
  182. Keir, 2014, Treatment of sarcoidosis-associated pulmonary hypertension: a single centre retrospective experience using targeted therapies, Sarcoidosis Vasc Diffuse Lung Dis, 31, 82
  183. Sulica, 2005, Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension, Chest, 128, 1483, 10.1378/chest.128.3.1483 · doi:10.1378/chest.128.3.1483
  184. Baughman, 2010, Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation, Chest, 138, 1078, 10.1378/chest.09-2002 · DOI · Paper page
  185. Baughman, 2018, Clinical features of sarcoidosis associated pulmonary hypertension: results of a multi-national registry, Respir Med, 139, 72, 10.1016/j.rmed.2018.04.015 · DOI
  186. Huitema, 2016, Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis, Eur Respir J, 47, 673, 10.1183/13993003.01319-2015 · DOI
  187. Duong, 2018, Sarcoidosis-associated pulmonary hypertension: pathophysiology, diagnosis, and treatment, Clin Pulm Med, 25, 52, 10.1097/CPM.0000000000000252 · DOI
  188. Galiè, 2015, 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Respir J, 46, 903, 10.1183/13993003.01032-2015 · DOI · Paper page
  189. Handa, 2006, Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis, Chest, 129, 1246, 10.1378/chest.129.5.1246 · DOI · Paper page
  190. Joyce, 2016, Prevalence and correlates of early right ventricular dysfunction in sarcoidosis and its association with outcome, J Am Soc Echocardiogr, 29, 871, 10.1016/j.echo.2016.06.001 · DOI
  191. Liu, 2017, Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension, Clin Respir J, 11, 906, 10.1111/crj.12435 · doi:10.1111/crj.12435
  192. Maimon, 2013, Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function, Int J Tuberc Lung Dis, 17, 406, 10.5588/ijtld.12.0428 · doi:10.5588/ijtld.12.0428
  193. Pabst, 2013, Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience, Adv Exp Med Biol, 755, 299, 10.1007/978-94-007-4546-9_38 · doi:10.1007/978-94-007-4546-9_38
  194. Patel, 2016, Right heart involvement in patients with sarcoidosis, Echocardiography, 33, 734, 10.1111/echo.13163 · doi:10.1111/echo.13163
  195. Rapti, 2013, Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors, Hai, 191, 61
  196. Baughman, 2006, Pulmonary hypertension in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 23, 108
  197. Fisher, 2006, Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment, Chest, 130, 1481, 10.1378/chest.130.5.1481 · doi:10.1378/chest.130.5.1481
  198. Bonham, 2015, Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series, Chest, 148, 1055, 10.1378/chest.14-2546 · DOI
  199. Barnett, 2009, Treatment of sarcoidosis-associated pulmonary hypertension: a two-center experience, Chest, 135, 1455, 10.1378/chest.08-1881 · DOI · Paper page
  200. Ford, 2016, Tadalafil therapy for sarcoidosis-associated pulmonary hypertension, Pulm Circ, 6, 557, 10.1086/688775 · doi:10.1086/688775

200 of 201 shown

Cited by

See all 1,086

Metadata

Authors
Crouser, E. D., Maier, L. A., Wilson, K. C., Bonham, C. A., Morgenthau, A. S., Patterson, K. C., Abston, E., Bernstein, R. C., Blankstein, R., Chen, E. S., Culver, D. A., Drake, W., Drent, M., Gerke, A. K., Ghobrial, M., Govender, P., Hamzeh, N., James, W. E., Judson, M. A., Kellermeyer, L., Knight, S., Koth, L. L., Poletti, V., Raman, S. V., Tukey, M. H., Westney, G. E., & Baughman, R. P.
Venue
American Journal of Respiratory and Critical Care Medicine
Publisher
Oxford University Press (OUP)
Published
2020-04-15
Volume
201
Issue
8
Pages
e26-e51
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
DOI
10.1164/rccm.202002-0251st
OpenAlex
W3015330439
Cited by
1,086
References
2
FWCI
66.88
Type
journal article
Language
en
Open access
hybrid
Licence
creativecommons.org/licenses/by-nc/4.0/ (vor, 2163 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. https://app.cochat.ai/papers/10.1164/rccm.202002-0251st
The paper
Crouser, E. D., Maier, L. A., Wilson, K. C., Bonham, C. A., Morgenthau, A. S., Patterson, K. C., Abston, E., Bernstein, R. C., Blankstein, R., Chen, E. S., Culver, D. A., Drake, W., Drent, M., Gerke, A. K., Ghobrial, M., Govender, P., Hamzeh, N., James, W. E., Judson, M. A., . . . Baughman, R. P. (2020). Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.202002-0251st

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.